PL401992A1 - 2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use - Google Patents

2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use

Info

Publication number
PL401992A1
PL401992A1 PL401992A PL40199212A PL401992A1 PL 401992 A1 PL401992 A1 PL 401992A1 PL 401992 A PL401992 A PL 401992A PL 40199212 A PL40199212 A PL 40199212A PL 401992 A1 PL401992 A1 PL 401992A1
Authority
PL
Poland
Prior art keywords
preparation
isoquinolin
benzoylamino
thiadiazole
medical use
Prior art date
Application number
PL401992A
Other languages
Polish (pl)
Other versions
PL221216B1 (en
Inventor
Agata Siwek
Monika Wujec
Anna Bielawska
Krzysztof Bielawski
Original Assignee
Uniwersytet Medyczny W Lublinie
Uniwersytet Medyczny W Białymstoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Uniwersytet Medyczny W Białymstoku filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL401992A priority Critical patent/PL221216B1/en
Publication of PL401992A1 publication Critical patent/PL401992A1/en
Publication of PL221216B1 publication Critical patent/PL221216B1/en

Links

Abstract

Przedmiotem wynalazku jest 2-benzoiloamino-5-(izochinolin-3-ylo)-1,3,4-tiadiazol o wzorze 1, sposób jego wytwarzania, zastosowanie związku o wzorze 1 jako leku do leczenia nowotworów piersi oraz jako substancji aktywnej do wytwarzania środków farmaceutycznych do leczenia nowotworów piersi.The subject of the invention is 2-benzoylamino-5- (isoquinolin-3-yl) -1,3,4-thiadiazole of formula 1, a method for its preparation, the use of a compound of formula 1 as a medicine for the treatment of breast cancer and as an active substance for the preparation of agents pharmaceuticals for treating breast cancer.

PL401992A 2012-12-11 2012-12-11 2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use PL221216B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL401992A PL221216B1 (en) 2012-12-11 2012-12-11 2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401992A PL221216B1 (en) 2012-12-11 2012-12-11 2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use

Publications (2)

Publication Number Publication Date
PL401992A1 true PL401992A1 (en) 2014-06-23
PL221216B1 PL221216B1 (en) 2016-03-31

Family

ID=50943658

Family Applications (1)

Application Number Title Priority Date Filing Date
PL401992A PL221216B1 (en) 2012-12-11 2012-12-11 2-benzoylamino-5-(isoquinolin-3-yl) -1,3,4-thiadiazole, a method for its preparation and the medical use

Country Status (1)

Country Link
PL (1) PL221216B1 (en)

Also Published As

Publication number Publication date
PL221216B1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
CY1119490T1 (en) PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT
CY1120703T1 (en) HETEROCYCLE COMPOUNDS AND THEIR USES
GEP20237479B (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
NZ751197A (en) Compounds and methods of treating infections
PH12016502355B1 (en) Pharmaceutical composition
EA201600204A1 (en) HINAZOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND THEIR APPLICATION FOR THE PREVENTION OR TREATMENT OF THE TUMOR
EA201491299A1 (en) CARBAMATIC CONNECTIONS, THEIR PRODUCTION AND APPLICATION
PH12017500493A1 (en) Combination therapy
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
EA201690754A1 (en) APPLICATION OF PCSK9 INHIBITOR FOR THE TREATMENT OF HYPERLIPIDEMIA
EA201691155A1 (en) COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES
EA201591781A1 (en) CHEMICAL COMPOUNDS
PH12016502352A1 (en) Pharmaceutical composition
EA201690386A1 (en) COMPOUNDS AND COMPOSITIONS AS MEK INHIBITORS
CY1122968T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A DIAMINO-HETEROCYCLIC CARBOXAMIDE COMPOUND AS AN ACTIVE INGREDIENT
TW201613578A (en) Pharmaceutical combinations
PH12015502616A1 (en) Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
CY1122899T1 (en) AQUEOUS FORMULATION INCLUDING PARACETAMOL AND IBUPROPHEN
PH12015502282A1 (en) Alpha-2 adrenoceptor and sigma receptor ligand combinations
TN2016000229A1 (en) Gabapentinoids and sigma receptor ligands combinations.
MX2015012455A (en) Method for the treatment of fatty liver disease.
BR102012028120B8 (en) USE OF ONE OR MORE INGENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND DRUG
UA117809C2 (en) BENDAMOUSTINE DERIVATIVES, RELATED COMPOUNDS AND THEIR MEDICAL APPLICATION FOR CANCER TREATMENT
BR112017002449A2 (en) treatment of symptoms associated with androgen deprivation therapy